Patents Assigned to Salhtech I Goteborg AB
  • Patent number: 6559289
    Abstract: The invention relates to the use of compounds selected from GH, analogues thereof, and GH-releasing compounds, optionally in combination with lipid-lowering agents or therapy, for the preparation of a drug for treatment of mammals with familial hypercholesterolemia of homozygous form.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: May 6, 2003
    Assignee: Salhtech I Goteborg AB
    Inventors: Mats Rudling, Bo Angelin